Anders Berkenstam
Gründer bei Axcentua Pharmaceuticals AB
Ursprung des Netzwerks ersten Grades von Anders Berkenstam
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden.
6
| Private Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Anders Berkenstam
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
University of Stockholm | College/University | Masters Business Admin Corporate Officer/Principal | |
GABATHER AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Cormorant Pharmaceuticals AB
Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder | |
Synphora AB
Synphora AB Pharmaceuticals: MajorHealth Technology The Swedish company was founded in 2004 by Johan Stjernschantz and is currently led by CEO Fredrik Henell. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
MetaCurUm Biotech AB | Chairman | ||
NANEXA AB | Medical Specialties | Director/Board Member | |
Life Science Group, Inc. | Medical Specialties | Corporate Officer/Principal | |
The Swedish Bar Association | Corporate Officer/Principal | ||
VITROLIFE AB | Medical Specialties | General Counsel | |
CAMURUS AB | Pharmaceuticals: Major | General Counsel | |
Nordia Law
Nordia Law Miscellaneous Commercial ServicesCommercial Services Nordia Law provides legal services. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
OREXO AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Lund | College/University | Graduate Degree | |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Biotechnology | Founder | |
LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Chairman | |
Buzzard Pharmaceuticals AB
Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Founder | |
Karlerö Liljeblad Advokatbyrå | Corporate Officer/Principal | ||
Evident Life Försäkring AB | Chairman | ||
Molecules of Man AB
Molecules of Man AB BiotechnologyHealth Technology Molecules of Man AB develops human monoclonal antibodies for treatment. The private company is based in Stockholm, Sweden. | Biotechnology | Chairman | |
Cavis Technologies AB | Chairman | ||
Brf-Bellman | Chairman | ||
Cordivest AB | Chairman | ||
Nylof Holding AB
Nylof Holding AB Investment Banks/BrokersFinance Nylof Holding AB provides security brokerage services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Urban Paulsson AB | Chairman | ||
Collective Minds Radiology AB
Collective Minds Radiology AB Packaged SoftwareTechnology Services Collective Minds Radiology AB provides a cloud-based healthcare service that enables collaboration, consultation, and access to new digital tools. The company is based in Danderyd, Sweden. The Swedish company was founded in 2017 by Pär Kragsterman, Anders Nordell, and Lennart Blomqvist. Anders Nordell has been the CEO since 2017. | Packaged Software | Director/Board Member | |
Bird & Bird LLP
Bird & Bird LLP Miscellaneous Commercial ServicesCommercial Services Bird & Bird LLP provide legal services. The firm focuses on aviation and aerospace, banking and financial services, communications, eCommerce, information technology, life sciences, media, and sports sectors. The company was founded in 1846 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lead Discovery Malaysia Sdn. Bhd. | Chief Executive Officer | ||
Nobel Pharma Chemistry
Nobel Pharma Chemistry Pharmaceuticals: OtherHealth Technology Part of Cambrex Corp., Nobel Pharma Chemistry is a Swedish company that specializes in producing bulk chemicals used in drugs. Nobel Pharma Chemistry was acquired by Cambrex Corp. from Akzo Nobel NV on October 13, 1994 for $130 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Karolinska Institutet | College/University | Doctorate Degree | |
University of Gothenburg | College/University | Undergraduate Degree | |
Royal Swedish Marine Academy | College/University | Undergraduate Degree | |
Premacure AB
Premacure AB Pharmaceuticals: MajorHealth Technology Premacure AB owns shares and acquires securities, patents, rights and licenses from other businesses. It is also involved in biotechnology and medicine. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Laccure AB
Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Orphan Europe SARL
Orphan Europe SARL Pharmaceuticals: MajorHealth Technology Orphan Europe SARL develops and distributes orphan drugs for the treatment of rare diseases. The firm's products include Normosang, Cystagon, Pedea, Carbaglu, Wilzin, Cystadane. The company was founded by William Gunnarsson in 1990 and is headquartered in Puteaux, France. | Pharmaceuticals: Major | Chief Executive Officer | |
RECORDATI | Pharmaceuticals: Major | Director/Board Member | |
Adenovir Pharma AB
Adenovir Pharma AB Pharmaceuticals: MajorHealth Technology Adenovir Pharma AB provides solutions for the treatment of eye diseases. The firm offers treatments and business development opportunities to the pharmaceutical industry. It manufactures antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC). The company was founded by Per Niklas Arnberg on December 11, 2007 and is headquartered in Helsingborg, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
PROSTALUND AB | Medical Specialties | Director/Board Member | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Laccure Development AB | Director/Board Member | ||
Premalux AB | Director/Board Member | ||
SENSIDOSE AB | Electronic Equipment/Instruments | Director/Board Member | |
Nobel Pharma, Inc.
Nobel Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Nobel Pharma, Inc. is a Japanese company that engages in the research and development of drugs. The private company is based in Tokyo, Japan. | Miscellaneous Commercial Services | President | |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member |
Statistik
International
Schweden | 42 |
Vereinigte Staaten | 5 |
Australien | 2 |
Malaysia | 2 |
Frankreich | 2 |
Sektoral
Health Technology | 26 |
Commercial Services | 6 |
Consumer Services | 6 |
Electronic Technology | 3 |
Finance | 2 |
Operativ
Director/Board Member | 22 |
Corporate Officer/Principal | 14 |
Chairman | 11 |
Founder | 9 |
Chief Executive Officer | 6 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Anders Berkenstam
- Unternehmensverbindungen